Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Helix Sementes E Mudas Ltda currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. This distribution indicates that the company's patent applications are being reviewed by different specialists within the biotechnology sector.
The busiest examiner for this portfolio is STANKOVIC, BRATISLAV, who is responsible for 1 pending office action. Since there are 2 pending office actions in total, the other action is assigned to another distinct examiner. This distribution between 2 examiners and 2 pending actions means that the company's active cases are split between different individuals.
Practitioners must manage 2 distinct art units, which may have different examination cultures or technical focuses. With 2 pending office actions spread across 2 distinct examiners, the company faces a decentralized prosecution process. Each of the 2 pending actions requires a tailored approach to satisfy the specific requirements of the different examiners and art units involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STANKOVIC, BRATISLAV | 1 | 70.0% | +21.9% |
| SHARMA, SANTOSH | 1 | 72.8% | +29.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17775168 | NUCLEIC ACID MOLECULE OF TRANSGENIC MAIZE EVENT ME240913 THAT EXPRESSES CRY1DA PROTEIN, CELL, PLANT AND TRANSGENIC SEED, USES THEREOF, PLANT PRODUCT, METHOD, KIT AND AMPLICON FOR DETECTING THE EVENT, AND METHODS TO PRODUCE A TRANSGENIC PLANT AND TO CONTROL LEPIDOPTERAN INSECT PESTS | STANKOVIC, BRATISLAV | — |
| 17053638 | CODON-OPTIMISED CRYIDA NUCLEIC ACID MOLECULE, NUCLEIC ACID CONSTRUCT, VECTOR, HOST CELL, PLANT CELL, TRANSGENIC PLANT, METHOD FOR TRANSFORMING A CELL, METHOD FOR PRODUCING A TRANSGENIC PLANT, METHOD FOR CONTROLLING INVERTEBRATE PESTS OF CROP PLANTS, AND USES OF THE NUCLEIC ACID MOLECULE | SHARMA, SANTOSH | — |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17775168 | NUCLEIC ACID MOLECULE OF TRANSGENIC MAIZE EVENT ME240913 THAT EXPRESSES CRY1DA PROTEIN, CELL, PLANT AND TRANSGENIC SEED, USES THEREOF, PLANT PRODUCT, METHOD, KIT AND AMPLICON FOR DETECTING THE EVENT, AND METHODS TO PRODUCE A TRANSGENIC PLANT AND TO CONTROL LEPIDOPTERAN INSECT PESTS | STANKOVIC, BRATISLAV | 1662 | §103 | Non-Final OA | — | Pending | Jan 12, 2023 |
| 17053638 | CODON-OPTIMISED CRYIDA NUCLEIC ACID MOLECULE, NUCLEIC ACID CONSTRUCT, VECTOR, HOST CELL, PLANT CELL, TRANSGENIC PLANT, METHOD FOR TRANSFORMING A CELL, METHOD FOR PRODUCING A TRANSGENIC PLANT, METHOD FOR CONTROLLING INVERTEBRATE PESTS OF CROP PLANTS, AND USES OF THE NUCLEIC ACID MOLECULE | SHARMA, SANTOSH | 1663 | §103 | Non-Final OA | — | Pending | Jun 23, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHelix Sementes E Mudas Ltda has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Bratislav Stankovic has the most, with 1 of Helix Sementes E Mudas Ltda's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
